Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
MicroRNA
62%
Differentially Expressed microRNAs
50%
Hematological Malignancies
50%
Breast Cancer Brain Metastasis
50%
Brain Metastases
50%
Patient Survival
50%
Chronic Lymphocytic Leukemia
37%
Prognostic Biomarker
37%
Multiple Myeloma
37%
Exosomal microRNA
25%
Neurological Diseases
25%
Biogenesis
16%
Extracellular Vesicles
16%
Exosomes
12%
Drug Delivery Vehicle
12%
Recipient Cells
12%
City Hospitals
12%
Transcriptome
12%
Glyco
12%
Unmet Medical Need
12%
Metastatic Process
12%
MiR-202
12%
Pathway Enrichment
12%
University of Liverpool
12%
Significance Analysis of Microarrays
12%
Expression Assay
12%
Survival Methods
12%
Prognostic Role
12%
C-Met
12%
MET Oncogene
12%
Metastasis-free Survival
12%
MiR-150-5p
12%
MiR-199a-5p
12%
NanoString nCounter
12%
MiR-132-3p
12%
Kaplan-Meier Survival
12%
MiR-155-5p
12%
Peterborough
12%
Diagnostic Tool
12%
Metastasis
12%
Oncology
12%
Neurology
12%
Exosome microRNAs
12%
Cancer Research
12%
Signaling Pathway
12%
Differentially Expressed
12%
Prognostic Tool
12%
Advancement of Knowledge
12%
Clinical Applicability
12%
Prognostic Marker
12%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Galectin-3
50%
Biogenesis
50%
Nucleic Acid
25%
Blood Brain Barrier
25%
Translocator Protein
25%
Blood Plasma
14%
Oncogene
8%
Metastasis Free Survival
8%
MiR-155
8%
Significance Analysis of Microarrays
8%
MiR-132
8%
Overall Survival
8%
Disease Burden
8%
Bone Remodeling
7%
Galactose
7%
Galactoside
7%
Microglobulin
7%
Next Generation Sequencing
7%
Homeostasis
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Binding Protein
7%
Immunology and Microbiology
Multiple Myeloma
100%
Galectin 3
66%
Prognostic Biomarker
50%
Blood Plasma
41%
Exosome
33%
Transcriptome
16%
Smoldering Multiple Myeloma
16%
Signal Transduction
16%
Disease Burden
5%